HRT Financial’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69K | Buy |
42,037
+15,795
| +60% | +$25.9K | ﹤0.01% | 1956 |
|
|
2025
Q1 | $41K | Buy |
+26,242
| New | +$41K | ﹤0.01% | 2021 |
|
|
2024
Q1 | – | Sell |
-10,043
| Closed | -$23K | – | 2990 |
|
|
2023
Q4 | $23K | Buy |
+10,043
| New | +$23K | ﹤0.01% | 1861 |
|
|
2023
Q2 | – | Sell |
-10,304
| Closed | -$31K | – | 3145 |
|
|
2023
Q1 | $31K | Buy |
+10,304
| New | +$31K | ﹤0.01% | 1973 |
|
|
2022
Q2 | – | Sell |
-909
| Closed | -$10K | – | 3599 |
|
|
2022
Q1 | $10K | Buy |
+909
| New | +$10K | ﹤0.01% | 2622 |
|
|
2021
Q4 | – | Sell |
-4,334
| Closed | -$108K | – | 3846 |
|
|
2021
Q3 | $108K | Sell |
4,334
-1,462
| -25% | -$36.4K | ﹤0.01% | 2613 |
|
|
2021
Q2 | $366K | Buy |
+5,796
| New | +$366K | ﹤0.01% | 1929 |
|
|
2021
Q1 | – | Sell |
-140
| Closed | -$15K | – | 2986 |
|
|
2020
Q4 | $15K | Buy |
+140
| New | +$15K | ﹤0.01% | 1679 |
|